Therapies

Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer

8 monthes ago   |   By Xconomy

Japanese drug giant Astellas Pharma announced late Monday it has agreed to buy Audentes Therapeutics, which is developing gene therapies for rare neuromuscular diseases. It's an all-cash deal worth $3 billion, with the Astellas offer of $60 per share representing a 110 percent premium to Audentes' share price of $28.61 apiece at market close Monday. The agreement is the latest big bet by a major pharmaceutical company on gene therapy, which aims to provide long-lasting, if not permanent, disease treatments. San Francisco-based Audentes' lead drug candidate, AT132, is a clinical-stage...
Read more ...

 

Astellas inks $3B Audentes buyout to expand in gene therapy

Astellas inks $3B Audentes buyout to expand in gene therapy

8 monthes ago   |   By Fierce Biotech

Astellas Pharma is set to buy Audentes Therapeutics for $3 billion. The deal will enable Astellas to set up a new genetic regulation unit spearheaded by a neuromuscular disease gene therapy that is set to be submitted for approval next year.
Read more ...

 


Search by Tags

   Therapies      Pharmaceutical      Pharma      Therapeutics      Drugs      Drug      Pharmaceuticals      Clinical      Gene      Genes      Gene Therapy      National      National blog main      National top stories      San Francisco blog main      San Francisco top stories      Acquisition      Antitrust      Astellas Pharma      Audentes      Big Pharma      Biotech      Buyout      Clinical trials      Deals      Drug Pricing      FDA      Joseph Schwartz      Life Sciences      M&A      Mergers      Neuromuscular disease      Orbimed      Rare disease      Regulatory review      Roche      Spark      Spark Therapeutics      Startup      SVB Leerink      Genetics  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political

Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political

Pfizer Inc. CEO Albert Bourla said he doesn't worry about political pressure to bring potentially the first coronavirus vaccine to market, but can't escape feeling the weight... Read more ...

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Ligand Pharmaceuticals plans to acquire recombinant protein therapeutics maker Pfenex for $438 million, the companies announced Monday. The larger company agreed to pay $12 per... Read more ...

Bayer Boosts Women's Health Drug Pipeline, Paying $425M for KaNDy

Bayer Boosts Women's Health Drug Pipeline, Paying $425M for KaNDy

Bayer has been building up its women's health drug pipeline by striking deals and on Tuesday the pharmaceutical giant unveiled its latest one : $425 million up front for KaNDy... Read more ...

In precisionFDA Challenge, PacBio HiFi Reads Outperform Both Short Reads and...

In precisionFDA Challenge, PacBio HiFi Reads Outperform Both Short Reads and Noisy Long Reads

Figure 1. PrecisionFDA Truth Challenge V2 Results. Of the single-technology entries, those that use PacBio HiFi reads delivered the highest accuracy in all categories... Read more ...

Keeping Cool Efficiently During Heat Waves

Keeping Cool Efficiently During Heat Waves

Berkeley Lab scientist Iain Walker Heat waves are becoming a more regular occurrence across the country. Iain Walker , Leader of the Residential Building Systems Group at... Read more ...

Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials

Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials

Results from four studies within a major Roche-run clinical trials program of an investigational gut disease drug have muddled the antibody's path forward after its performance... Read more ...

International Physicists Join Forces in Hunt for Sterile Neutrinos

International Physicists Join Forces in Hunt for Sterile Neutrinos

These four Daya Bay detectors are submerged in a pool of ultrapure water that helps to shield against naturally occurring radiation. Note: This press release is adapted from... Read more ...

Part-Time Logistics Coordinator

Job Duties Logistics: -Will require basic lab work such as: aliquoting, dilutions, and lyophilizing -Help set up and pack shipping boxes daily, generating shipping labels... Read more ...

'AeroNabs' promise powerful, inhalable protection against COVID-19

Scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes COVID-19. The researchers engineered a completely synthetic... Read more ...

ACADIA Pharmaceuticals to Present at The JMP Securities CNS Forum on August...

SAN DIEGO--ACADIA Pharmaceuticals Inc. today announced that it will present at The JMP Securities CNS Forum on Wednesday, August 19, 2020, at 11:00 a.m. Eastern Time. The... Read more ...